New digital scope aims to spot bile duct cancer more accurately
NCT ID NCT03307382
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new digital scope (SpyGlass DS) to help doctors tell cancerous from non-cancerous narrowings in the bile duct. About 40 adults with bile duct strictures will undergo the procedure during a standard ERCP exam. The goal is to see if the digital scope improves diagnosis accuracy compared to older methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SpyGlass DS Cholangioscopy device
- What this could lead to
- If successful, this could give doctors a more accurate way to diagnose bile duct strictures without more invasive tests.
- What could go wrong
- This is a small, early study with only 40 people, so results may not apply to everyone. The device may not be better than current methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY STRICTURE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prince of Wales Hospital, The Chinese University of Hong Kong
Shatin, New Territories, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New scope may spot bile duct cancer faster
- Which biopsy method best spots bile duct cancer?
- AI reads bile duct scans in real time to spot cancer
- New registry tracks best way to fix bile duct blockages in liver transplant patients
- New registry aims to improve bile duct stone removal
- Which ERCP rescue method is safer? major trial launches